IBB vs SCHX
iShares Biotechnology ETF vs Schwab US Large-Cap ETF
IBB$197.34
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: 0.44%Yield: 0.22%
SCHX$29.63
Schwab US Large-Cap ETF
Low-cost US large-cap exposure.
Expense: 0.03%Yield: 1.03%
Quick take
- • SCHX has the lower expense ratio at 0.03% vs 0.44% for IBB.
- • SCHX pays a higher dividend yield (1.03%).
Side-by-side metrics
| Metric | IBB | SCHX |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.03% |
Dividend yield Trailing 12-month yield. | 0.22% | 1.03% |
AUM Assets under management — bigger funds are typically more liquid. | $9.09B | $71.64B |
YTD return | 16.44% | 9.81% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.69 | 1.02 |
P/E ratio | 24.89 | 26.73 |
Last price | $197.34 | $29.63 |
Inception | — | — |
Issuer | iShares | Schwab |
IBB top holdings
Top holdings · IBB
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
Sector breakdown · IBB
Healthcare100.0%
SCHX top holdings
Top holdings · SCHX
| NVDA | NVIDIA Corp | 7.01% |
| AAPL | Apple Inc | 6.15% |
| MSFT | Microsoft Corp | 4.07% |
| AMZN | Amazon.com Inc | 3.49% |
| GOOGL | Alphabet Inc Class A | 3.08% |
| AVGO | Broadcom Inc | 2.62% |
| GOOG | Alphabet Inc Class C | 2.47% |
| MU | Micron Technology Inc | 1.92% |
| META | Meta Platforms Inc Class A | 1.84% |
| TSLA | Tesla Inc | 1.72% |
Sector breakdown · SCHX
Real Estate2.1%
Consumer Cyclical9.6%
Basic Materials1.8%
Consumer Defensive4.6%
Technology36.7%
Communication Services9.7%
Financial Services11.7%
Utilities2.2%
Industrials9.4%
Energy3.1%
Healthcare9.2%
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About SCHX
SCHX (Schwab US Large-Cap ETF) is Low-cost US large-cap exposure. Managed by Schwab, the fund carries $71.6B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.03%. Its largest holding is NVIDIA Corp (NVDA), which represents 7.0% of the portfolio. Real Estate is the fund's largest sector exposure at 2.1%.